NOVEL IL-17R-ECD MUTANTS
    1.
    发明申请
    NOVEL IL-17R-ECD MUTANTS 有权
    新型IL-17R-ECD突变体

    公开(公告)号:US20150025022A1

    公开(公告)日:2015-01-22

    申请号:US14232921

    申请日:2012-07-18

    摘要: Provided are engineered soluble hIL-17RA receptors with high affinity to hIL-17 that inhibit downstream IL17A induced signaling events in cells. Also provided are methods of inhibiting hIL-17A induced secretion of CXCL1 and/or IL-6 in cells, as well as methods of treating inflammation and/or inflammatory disorders in a subject.

    摘要翻译: 提供了对hIL-17具有高亲和力的工程可溶性hIL-17RA受体,其抑制下游IL17A诱导细胞中的信号传导事件。 还提供了抑制细胞中hIL-17A诱导的CXCL1和/或IL-6分泌的方法,以及治疗受试者的炎症和/或炎症性疾病的方法。